Barratt, J., Desai, A., Fornoni, A., Inker, L., Noronha, I. d. L., Quevedo, A., . . . Heerspink, H. L. WCN24-1132 ACTION3 – Phase 3 study of DMX-200 for the treatment of focal segmental glomerulosclerosis (FSGS). Elsevier.
Chicago Style (17th ed.) CitationBarratt, Jonathon, et al. WCN24-1132 ACTION3 – Phase 3 Study of DMX-200 for the Treatment of Focal Segmental Glomerulosclerosis (FSGS). Elsevier.
MLA (9th ed.) CitationBarratt, Jonathon, et al. WCN24-1132 ACTION3 – Phase 3 Study of DMX-200 for the Treatment of Focal Segmental Glomerulosclerosis (FSGS). Elsevier.
Warning: These citations may not always be 100% accurate.